If you or a loved one has ever struggled with high cholesterol, you know how frustrating it can be to manage it with diet and medication. For many heart disease patients, even strong statin doses don’t bring LDL levels down enough. Now, a new pill being tested in clinical trials could change the way doctors treat cholesterol and it doesn’t involve needles.
In a recent video on the YouTube channel @TheStudiesGuy, speaker Joseph Minkowitz explains why this new treatment is generating so much excitement. Unlike costly injectable drugs many patients avoid, this pill could do the job almost as well, and more people might be willing to take it.
New Oral Pill Shows Promise For Cholesterol Control
Traditional treatment for stubborn cholesterol often includes PCSK9 inhibitors, which require injections and are costly. Because of this, most patients never use them and many doctors don’t prescribe them. But the new drug in the spotlight is different.
Dr Anne Marie Navar led a large phase 3 clinical trial involving 2,909 participants to test a pill called Enlicitide. According to the trial results, the pill reduced “bad” LDL cholesterol by up to 57% — a huge improvement for an oral medication. Even more impressive:
DON'T MISS
- Over 70% of patients hit their cholesterol targets in the trial
- The reduction seen with this pill is one of the largest ever achieved with a non‑injectable drug
- Researchers say it may be the most effective oral cholesterol treatment since statins
Dr Navar called the results “the most effective cholesterol reduction anyone has ever achieved with an oral medication since statins were developed.”
However, it’s important to note that this drug is still investigational. It has not yet been approved by the FDA, so it isn’t available for general use yet.
Why An Oral Pill Matters
According to experts, one of the biggest problems in heart health is adherence — patients simply don’t take their medications consistently. This is especially true for injectable drugs that require regular clinic visits or self‑injection. An effective once‑daily pill could solve this problem.
Here’s why this matters:
- More patients might stick with treatment when no injections are needed.
- A daily pill could improve outcomes and reduce risk of heart attacks and strokes.
- If approved, it could become a new standard in how doctors treat cholesterol worldwide.
As research continues, many in the medical community are watching this closely. If future results match the early promise, this pill could mark a major shift in heart health care.
